相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study
C. Dominguez et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience
Andrea Negro et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Analysis of longitudinal data from animals with missing values using SPSS
Denise A. Duricki et al.
NATURE PROTOCOLS (2016)
Medication-overuse headache: risk factors, pathophysiology and management
Hans-Christoph Diener et al.
NATURE REVIEWS NEUROLOGY (2016)
Headache disorders are third cause of disability worldwide
Timothy J. Steiner et al.
JOURNAL OF HEADACHE AND PAIN (2015)
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study
Andrea Negro et al.
SPRINGERPLUS (2015)
Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK
Modar Khalil et al.
JOURNAL OF HEADACHE AND PAIN (2014)
The International Classification of Headache Disorders, 3rd edition (beta version)
Andre Bes et al.
CEPHALALGIA (2013)
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline
Stephen D. Silberstein et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Theo Vos et al.
LANCET (2012)
OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine
R. B. Lipton et al.
NEUROLOGY (2011)
Global prevalence of chronic migraine: A systematic review
J. L. Natoli et al.
CEPHALALGIA (2010)
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
S. K. Aurora et al.
CEPHALALGIA (2010)
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
H. C. Diener et al.
CEPHALALGIA (2010)
Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program
Andrew Blumenfeld et al.
HEADACHE (2010)
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study
H-C Diener et al.
CEPHALALGIA (2007)
Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial
Stephen D. Silberstein et al.
HEADACHE (2007)
Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness
P. Zeeberg et al.
CEPHALALGIA (2006)
分享论文
